Editas Medicine Statistics

Total Valuation

Editas Medicine has a market cap or net worth of $153.19 million. The enterprise value is -$36.64 million.

Market Cap	153.19M
Enterprise Value	-36.64M

Important Dates

The last earnings date was Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Editas Medicine has 83.71 million shares outstanding. The number of shares has increased by 4.29% in one year.

Current Share Class	83.71M
Shares Outstanding	83.71M
Shares Change (YoY)	+4.29%
Shares Change (QoQ)	+0.53%
Owned by Insiders (%)	0.36%
Owned by Institutions (%)	53.67%
Float	83.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.22
Forward PS	n/a
PB Ratio	2.45
P/TBV Ratio	2.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.08, with a Debt / Equity ratio of 0.50.

Current Ratio	3.08
Quick Ratio	3.03
Debt / Equity	0.50
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-93.52

Financial Efficiency

Return on equity (ROE) is -140.82% and return on invested capital (ROIC) is -61.37%.

Return on Equity (ROE)	-140.82%
Return on Assets (ROA)	-36.80%
Return on Invested Capital (ROIC)	-61.37%
Return on Capital Employed (ROCE)	-108.77%
Revenue Per Employee	$145,679
Profits Per Employee	-$1.02M
Employee Count	246
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.60% in the last 52 weeks. The beta is 2.15, so Editas Medicine's price volatility has been higher than the market average.

Beta (5Y)	2.15
52-Week Price Change	-65.60%
50-Day Moving Average	1.40
200-Day Moving Average	2.21
Relative Strength Index (RSI)	62.54
Average Volume (20 Days)	1,847,103

Short Selling Information

The latest short interest is 9.09 million, so 10.86% of the outstanding shares have been sold short.

Short Interest	9.09M
Short Previous Month	11.61M
Short % of Shares Out	10.86%
Short % of Float	10.90%
Short Ratio (days to cover)	5.53

Income Statement

In the last 12 months, Editas Medicine had revenue of $35.84 million and -$251.23 million in losses. Loss per share was -$3.04.

Revenue	35.84M
Gross Profit	-161.41M
Operating Income	-207.24M
Pretax Income	-193.45M
Net Income	-251.23M
EBITDA	-200.92M
EBIT	-207.24M
Loss Per Share	-$3.04

Full Income Statement

Balance Sheet

The company has $220.96 million in cash and $31.13 million in debt, giving a net cash position of $189.83 million or $2.27 per share.

Cash & Cash Equivalents	220.96M
Total Debt	31.13M
Net Cash	189.83M
Net Cash Per Share	$2.27
Equity (Book Value)	62.42M
Book Value Per Share	0.75
Working Capital	151.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$208.21 million and capital expenditures -$7.07 million, giving a free cash flow of -$215.28 million.

Operating Cash Flow	-208.21M
Capital Expenditures	-7.07M
Free Cash Flow	-215.28M
FCF Per Share	-$2.57

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-578.28%
Pretax Margin	-701.04%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Editas Medicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.29%
Shareholder Yield	-4.29%
Earnings Yield	-163.99%
FCF Yield	-140.53%

Analyst Forecast

The average price target for Editas Medicine is $6.73, which is 267.76% higher than the current price. The consensus rating is "Buy".

Price Target	$6.73
Price Target Difference	267.76%
Analyst Consensus	Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	-10.02%
EPS Growth Forecast (5Y)	-13.97%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Editas Medicine has an Altman Z-Score of -9.1 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.1
Piotroski F-Score	1